To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Amendment to Purchase Order #20985 with Abbott Laboratories
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, an amendment to purchase order #20985 with Abbott Laboratories to increase the payment limit by $500,000 to a new payment limit not to exceed $2,200,000 to purchase testing reagents and kits for HIV, Hepatitis A, Hepatitis B, and Hepatitis C screening at the Contra Costa Public Health Laboratory with no change to the original term of October 1, 2020 through December 31, 2024.
FISCAL IMPACT:
Approval of this action will result in an additional $500,000 in expenditures for testing reagents and kits and will be funded by the Hospital Enterprise Fund 1 revenues.
BACKGROUND:
Contra Costa County Public Health Laboratory currently provides HIV and Hepatitis antibody testing for all Contra Costa Health clinic patients for routine care, including Contra Costa Regional Medical Center.
On November 17, 2020, the Board of Supervisors approved agenda item C.41 to execute a purchase order (#20985) with Abbott Laboratories, in the amount of $800,000 for the period from October 1, 2020 through September 30, 2022 to purchase Hepatitis testing kits and reagents.
On October 4, 2022, the Board of Supervisors approved agenda item C.53 to execute an amendment to purchase order #20985 with Abbott Laboratories to increase the payment limit to a new total not to exceed $1,700,000 to purchase testing reagents for Hepatitis A, Hepatitis B, Hepatitis C, and COVID-19 antibody screening and extend the term through December 31, 2024.
This purchase order amendment would allow the Public Health Laboratory to continue purchasing antibody screening test kits for the Abbott Architect instrument and continue to meet the increasing demand for HIV and Hepatitis testing kits and reagents as well as allow for additional programs to be added to the testing menu.
Abbott Laboratories is the sole provider of the full menu of readily available reagents for the Abbott Architect instrument and the laboratory has used the Architect instrument, as well as an earlier version, since 2012. On August 7, 2024, the Purchasing Agent approved the continued use of Abbott Laboratories.
CONSEQUENCE OF NEGATIVE ACTION:
If this action is not approved, the Contra Costa Public Health Laboratory would not be able to purchase HIV and Hepatitis antibody screening kits for patient care. Additionally, invoices would not be paid in a timely manner.